The Current Status and Future Perspectives of Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Endometrial Cancer

Endometrial cancer (EC) is a gynecological neoplasm that is increasing in occurrence and mortality rates. Although endometrial cancer in the early stages shows a relatively favorable prognosis, there is an increase in cancer-related mortality rates in the advanced or recurrent endometrial carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ji-Young, Kim, Tae-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136476/
https://www.ncbi.nlm.nih.gov/pubmed/37185744
http://dx.doi.org/10.3390/cimb45040220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136476/
https://www.ncbi.nlm.nih.gov/pubmed/37185744
http://dx.doi.org/10.3390/cimb45040220

Ejemplares similares